In cases where the patient “fulfills the revised Bethesda guidelines, but not the Amsterdam criteria II, or does not have a personal or family history strongly suggestive of Lynch syndrome,” if the results of MSI testing show MSI-H or loss of MMR proteins expression, the patient may have Lynch syndrome (many patients are likely to have sporadic colorectal cancer). Here, MRC1 is linked to Lynch syndrome.